Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients. Watanabe H, Shirai T, Hirai K, Akamatsu T, et al. J Asthma 2021 Aug 4:1-12. doi: 10.1080/02770903.2021.1963769.

Read + Share

Amedeo Smart

Independent Medical Education

Watanabe H, Shirai T, Hirai K, Akamatsu T, et al. Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients. J Asthma 2021 Aug 4:1-12. doi: 10.1080/02770903.2021.1963769.
PMID: 34348060